App EULA & Terms of use

GLUCOSENSOR.COM APP END-USER LICENSE AGREEMENT (EULA) AND TERMS OF USE

INTRODUCTION
This End-User License Agreement (“Agreement”) is a binding contract between you (the “User”) and DiaX Medical B.V. (“DiaX Medical”), the provider of the GlucoSensor™ mobile App. By using the GlucoSensor™ App (the “App”), you agree to the terms of this Agreement. Please read it carefully along with our Privacy Policy and Legal Disclaimer for the App, which are incorporated by reference. If you do not agree with these terms, do not download, install, or use the App.

Important Note: For clarity, there are two distinct Legal Disclaimer documents incorporated by reference into this Agreement: the Legal Disclaimer for the App, governing your use of the GlucoSensor™ App and CGM System, and the Legal Disclaimer for the Website, governing your interactions with the GlucoSensor.com website.

MEDICAL DISCLAIMER (SUMMARY)
The GlucoSensor™ App and related content are provided for informational purposes only and are not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions about a medical condition.

The GlucoSensor™ Continuous Glucose Monitoring (CGM) System provides indicative interstitial fluid glucose values, which may differ from blood glucose levels. You must confirm any App-provided glucose reading with a fingerstick blood glucose test (using a traditional glucose meter) before making any medical decisions or treatment changes. Always follow the guidance of a physician or qualified healthcare professional regarding treatment or diagnosis.

The GlucoSensor™ CGM System is not intended for critical care, life-support, or emergency medical use. Do not rely on the App or CGM System in life-threatening situations or emergencies. In case of a suspected medical emergency (e.g. severe hypo- or hyperglycaemia), seek immediate medical attention or call emergency services — do not use the App as a substitute for emergency care. DiaX Medical disclaims any liability for health outcomes if the CGM System is used in emergency or other high-risk situations without proper medical oversight.

This summary is provided for convenience. Please refer to the full Legal Disclaimer for the App (incorporated by reference into this Agreement) for a comprehensive list of warnings and limitations. By using the App, you acknowledge these critical disclaimers. If you cannot accept these limitations, do not use the GlucoSensor™ App.

DEFINITIONS
For purposes of this Agreement, the following definitions apply:

App – The GlucoSensor™ mobile App provided by DiaX Medical for use with the GlucoSensor™ CGM System, including any updates, upgrades, or enhancements.
GlucoSensor™ CGM System – The Continuous Glucose Monitoring (CGM) system consisting of the glucose sensor, transmitter, and the associated GlucoSensor™ App. It provides continuous indicative glucose readings intended for adjunctive use in diabetes management, wellness and lifestyle purposes, weight management, and general metabolic health monitoring.
DiaX Medical – DiaX Medical B.V., registered at Vincent van Goghweg 5, 1861 CD Bergen, Netherlands. DiaX Medical is the EU distributor and operator of the GlucoSensor™ App, responsible exclusively for:
- placing the GlucoSensor™ CGM System on the EU market (acting as the EU Importer);
- server infrastructure, app availability, marketing, and customer support within the EU;
- design, development, and management of the GlucoSensor™ App’s user interface (UI) and user experience (UX), including the visual presentation, layout, navigation, interactions, accessibility, and usability of the App, as well as ensuring that these aspects comply fully with applicable EU regulatory and data protection requirements.

DiaX Medical explicitly disclaims responsibility for the CGM System’s underlying medical technology, core medical algorithms, medical Software Development Kit (SDK), and all medical data accuracy and outputs provided by the SDK, including glucose measurements, glucose trend analyses, glucose graphs, and any related clinical information displayed within the App. DiaX Medical has no ability to influence, modify, or control the medical data, measurements, or medical outputs generated by the SDK, all of which remain exclusively the responsibility of MicroTech Medical.

MicroTech Medical –MicroTech Medical (Hangzhou) Co., Ltd., registered at No. 108 Liuze St., Cangqian, Yuhang District, Hangzhou, 311121, Zhejiang, China. MicroTech Medical is the legal manufacturer of the GlucoSensor™ CGM System, including the glucose sensor, transmitter hardware, core medical algorithms, and the medical Software Development Kit (SDK) embedded within the GlucoSensor™ App.

The SDK provided by MicroTech Medical is a self-contained software package integrated into the App, containing proprietary medical algorithms, glucose measurement technology, glucose data processing functionalities, and other critical medical components necessary for providing continuous glucose monitoring data and clinical outputs. MicroTech Medical retains exclusive control over the SDK, including its maintenance, accuracy, reliability, performance, medical validation, regulatory compliance, updates, and enhancements.

MicroTech Medical is solely responsible for all medical device regulatory obligations, including maintaining CE marking under EU laws, as well as the medical accuracy, reliability, and performance of glucose measurements, glucose trends, graphical data representations, and all related clinical or medical outputs generated by the SDK. DiaX Medical has no visibility, ability to modify, or control over the functionality or outputs of the SDK.

Authorized Representative (AR) – Lotus NL B.V., registered at Koningin Julianaplein 10, 2595 AA, ‘s-Gravenhage, the Netherlands, registered in the Trade Register of the Dutch Chamber of Commerce under number 72313072. Lotus NL B.V. is the authorized representative of MicroTech Medical in the European Union, responsible for liaising with EU regulatory authorities and ensuring the GlucoSensor™ CGM System’s compliance with applicable EU medical device regulations.
User (also “you” or “your”) – Any individual who downloads, installs, or uses the GlucoSensor™ App. The User may also be referred to as a patient or consumer of the GlucoSensor™ CGM System services.
Device – A compatible mobile device (smartphone or tablet) owned or controlled by the User, on which the App is installed and used.
Services – The features and functionalities provided through the App, including continuous glucose monitoring data display, trend analysis, alerts, and any other services or support offered via the App.
Data – All information collected, generated, or processed by the App, including personal information, health data (such as glucose readings), usage statistics, and device information.
Privacy Policy – DiaX Medical’s Privacy Policy governing how personal and health data are collected, used, shared, and protected. The Privacy Policy applies to the App and is incorporated into this Agreement by reference.
Legal Disclaimer for the App – The detailed Medical and Legal Disclaimer for the GlucoSensor™ App and CGM System, which provides comprehensive warnings, intended use limitations, and liability exclusions. The Legal Disclaimer is incorporated into this Agreement by reference and supplements the terms herein.
Legal Disclaimer for the Website – The separate disclaimer document governing your interactions with the GlucoSensor.com website, covering limitations of liability, usage terms, product information, educational content, and commercial functionalities. This document is incorporated by reference into this Agreement.

ARTICLE 1: INTRODUCTION AND ACCEPTANCE OF TERMS
This Agreement is exclusively between you, the User, and DiaX Medical B.V., who is the licensor of the GlucoSensor™ App. MicroTech Medical Inc. and Lotus NL B.V. are not contracting parties but fulfil specific regulatory and manufacturing responsibilities described elsewhere in this Agreement.

1.1 OVERVIEW
This Agreement sets forth the terms and conditions for using the GlucoSensor™ App, which is part of the GlucoSensor™ Continuous Glucose Monitoring System. The App is provided by DiaX Medical to help Users track indicative glucose trends. The App is intended as a supplementary tool for glucose monitoring and does not replace professional medical advice, diagnosis, or traditional blood glucose testing methods. DiaX Medical provides the App under the regulations applicable to medical devices in the EU, and usage outside the intended scope is at the User’s own risk.

Important Notes:

Intended age and supervision: The GlucoSensor™ CGM System is medically validated for Users aged 14 and older. If you are under 14 years old, you are not permitted to use the App or CGM System. Users between 14 and the age of legal majority in their country must only use the App under the consent and supervision of a parent or legal guardian. Such minor use should also involve consultation with, and guidance from, a qualified healthcare professional to ensure safe and appropriate system use. By using the App, you confirm that you meet the applicable age requirements or have obtained the necessary parental consent.
Specific populations: The GlucoSensor™ System has not been evaluated for certain populations (including, but not limited to, individuals on dialysis or those with implanted electronic medical devices like pacemakers). Use by these individuals is not recommended unless a qualified healthcare professional has expressly approved it.
Usage constraints: Always use the App and CGM System in accordance with the provided instructions and under appropriate medical guidance. DiaX Medical disclaims any liability for outcomes resulting from improper or unauthorized use of the App or CGM System, especially use that is contrary to these terms or without recommended medical supervision.
Read incorporated documents: Please review this Agreement in conjunction with our Privacy Policy and the Legal Disclaimer for the App. These documents contain important information about User responsibilities, data handling, and limitations of liability related to using the App and CGM System.

1.2 SCOPE OF THIS APP EULA
This Agreement applies exclusively to the use of the GlucoSensor™ App and related services. It governs software licensing, App functionalities, data usage in the App, and associated user obligations. Any use of the GlucoSensor.com website or purchase of GlucoSensor products is outside the scope of this App EULA and is governed explicitly by the separate Website EULA and General Delivery Terms. In other words, this App EULA focuses on your interactions with the mobile application and does not cover website transactions or product ordering and delivery conditions, which are addressed in the Website EULA and General Delivery Terms, respectively.

1.3 ROLES AND RESPONSIBILITIES (SUMMARY)
For detailed definitions and responsibilities of DiaX Medical (Importer/Distributor), MicroTech Medical (Manufacturer), and Lotus NL B.V. (Authorized Representative), refer explicitly to the Definitions section above.

Key Regulatory Obligations:

DiaX Medical: Responsible as EU Importer and distributor, ensuring EU regulatory compliance for product placement, traceability, distribution, customer support, and GDPR compliance. DiaX Medical explicitly disclaims responsibility for medical algorithms and SDK accuracy.
MicroTech Medical: Solely responsible for CE certification, medical accuracy, safety, efficacy, and all medical device regulatory obligations (MDD/MDR), including vigilance reporting.
Authorized Representative (Lotus NL B.V.): Represents MicroTech Medical in EU regulatory interactions, vigilance reporting, compliance audits, and technical documentation maintenance.

1.4 ACCEPTANCE OF TERMS
By downloading, installing, or using the GlucoSensor™ App, you expressly acknowledge that you have read, understood, and agree to be bound by this Agreement and all documents incorporated by reference, including the Privacy Policy and the Legal Disclaimer for the App. If you do not agree with any part of these terms or the related documents, you must not download, install, or use the App. Continuing to use the App indicates your acceptance of this EULA in its entirety.

1.5 RELATED DOCUMENTS AND LEGAL FRAMEWORK
Your use of the GlucoSensor™ App is part of a broader legal framework that includes additional terms and policies. The following documents are incorporated by reference into this EULA and collectively govern your use of GlucoSensor™ products and services:

Privacy Policy: Explains how DiaX Medical collects, uses, and protects your personal data and health information when you use the App. It outlines your data protection rights in accordance with the GDPR and other applicable laws and our obligations concerning your information.
Website EULA: The End-User License Agreement for GlucoSensor.com, which governs use of the GlucoSensor website including creating accounts and purchasing products online. If you use our website in addition to the App, the Website EULA applies to those website interactions.
General Delivery Terms: The terms and conditions that apply to ordering, payment, delivery, and receipt of physical products (such as sensors or transmitters) from DiaX Medical. These terms ensure you know your rights and responsibilities when buying GlucoSensor products.
Returns and Refund Policy: Outlines the conditions and process for returning products and obtaining refunds for purchases made through GlucoSensor.com or authorized channels, including time limits and product condition requirements.
Sensor Replacement Policy: Specifies how and when sensors will be replaced under warranty or guarantee, including any limitations or exclusions (for example, conditions that void the warranty).
Legal Disclaimer for the App: Provides detailed limitations of liability, medical warnings, intended use guidelines, and important safety information specifically applicable to the GlucoSensor™ App and the CGM System.
Legal Disclaimer for the Website: Defines limitations of liability, usage terms, and disclaimers specifically related to your interactions with the GlucoSensor.com website, including product information, educational content, and commercial functionalities.

These documents collectively form the comprehensive legal agreement between you and DiaX Medical regarding GlucoSensor products and services. In case of any conflict between this App EULA and one of the above documents, the more specific document for the issue will take precedence. For example, privacy-related matters are governed by the Privacy Policy, and medical use limitations are detailed in the Legal Disclaimer for the App. All documents should be read together for a full understanding of your rights and obligations.

1.6 Changes to this Agreement
DiaX Medical reserves the right to modify or update this Agreement at any time. If we make material changes, we will notify you prominently within the App or by email, clearly describing the changes made. Changes will become effective immediately upon posting or notification, unless otherwise specified. Continued use of the App after the posting of such changes constitutes your acceptance of the modified terms. If you do not accept the modified terms, you must stop using the App and uninstall it from your device.

1.7 Geographic Scope
The GlucoSensor™ App and CGM System are developed to comply with European Union laws and regulations including medical device requirements. While the App may be accessible or usable in other regions, we make no representation that the App is appropriate or available for use outside of jurisdictions where we have obtained regulatory approvals. Users who access or use the App outside the EU are responsible for compliance with local laws and regulations. Use of the GlucoSensor™ System in a country where it is not approved or not in compliance with local medical device regulations is at the User’s own risk. DiaX Medical disclaims liability for use of the App in any jurisdiction where such use would violate local law or regulatory requirements. Users should ensure that using the App is legal and appropriate in their location.

ARTICLE 2: TERMS OF USE

2.1 LICENSE TO USE THE APP
Your license rights and restrictions are defined explicitly in Article 3 (License Grant and Restrictions).

2.2 USER OBLIGATIONS AND RESPONSIBILITIES
When using the App, you have explicit responsibilities, including:

Ensuring your mobile device is compatible with the App, maintaining adequate device security, regularly installing provided software updates, and ensuring sufficient battery life and connectivity.
Providing accurate, current, and complete personal and health-related information when creating or managing your user account or during App usage.
Verifying unexpected, inconsistent, or critical glucose readings provided by the App using traditional fingerstick blood glucose tests before making any medical decisions or treatment adjustments.
Consulting a qualified healthcare provider concerning your medical conditions. The App is supplementary and does not replace professional medical judgment or traditional glucose measurement methods.

Third-party Authentication and Multi-Factor Authentication (MFA)
The GlucoSensor™ App integrates third-party authentication provided by MiniOrange to securely manage user logins and account access, including the use of Multi-Factor Authentication (MFA). By using the App, you explicitly consent to your login information and MFA credentials being securely managed by MiniOrange. You are responsible for safeguarding your account credentials, including any MFA codes or tokens generated through MiniOrange’s authentication system. DiaX Medical explicitly disclaims all liability for unauthorized access to your account due to compromised login credentials or inadequate personal security practices.

2.3 DEVICE SHARING PROHIBITION AND RISKS
The GlucoSensor™ CGM System (including the sensor, transmitter, and your App account) is licensed for use by one individual only. You must not share the App, your user account, any CGM sensor or transmitter, or related data with any other person. Sharing any component of the system can lead to inaccurate readings, compromised data integrity, missed or incorrect alerts, and serious health or safety risks. DiaX Medical and MicroTech Medical disclaim all liability for harm or damage resulting from unauthorized sharing or use by anyone other than the registered user. You are solely responsible for any consequences arising from allowing another person to use your GlucoSensor App, account, or device.

2.4 THIRD-PARTY PLATFORM TERMS (APPLE APP STORE / GOOGLE PLAY STORE)
If you obtained the App through third-party platforms, such as Apple App Store or Google Play Store, the following platform-specific conditions apply:

Apple App Store:
You acknowledge that this Agreement is exclusively between you and DiaX Medical, not Apple Inc. Apple is not responsible or liable for the App, its content, support, maintenance, or warranty. Apple expressly disclaims all warranty obligations regarding the App. You further agree that Apple, as a third-party beneficiary, can enforce the terms of this Agreement against you. You also affirm that you are not located in a country under U.S. government embargo nor are listed as prohibited or restricted by the U.S. government.

Google Play Store:
You acknowledge this Agreement is exclusively between you and DiaX Medical, not Google LLC. Google is not responsible for the App or its associated services, support, or warranties. Google disclaims all obligations relating to the App, including warranty claims or liabilities. You agree to comply fully with Google Play’s Terms of Service when using the App. Google and its affiliates are third-party beneficiaries of this Agreement, with the right to enforce these terms directly against you.

Except for the specific third-party beneficiary rights expressly granted to Apple and Google in this Article, this Agreement does not confer any rights or remedies on any other third parties.

ARTICLE 3: LICENSE GRANT AND RESTRICTIONS

3.1 LICENSE GRANT
DiaX Medical grants you a limited, non-exclusive, non-transferable, revocable license to download, install, and use the GlucoSensor™ App solely for your personal, non-commercial use in conjunction with the GlucoSensor™ CGM System. This license is granted exclusively subject to your strict adherence to the terms and conditions set forth in this Agreement.

3.2 LICENSE RESTRICTIONS
You shall not:

Reverse engineer, decompile, disassemble, modify, or create derivative works of the App or its underlying technology (except to the limited extent allowed by law or using any in-app settings provided for customization);
Distribute, sublicense, lease, rent, lend, sell, or otherwise commercially exploit the App or any part of it;
Use the App or CGM System for any unlawful or unauthorized purpose, including any use that violates medical device regulations or could jeopardize anyone’s health or safety;
Circumvent, disable, or interfere with any security feature of the App or attempt to gain unauthorized access to any part of the App (such as by hacking or altering the App), which would compromise its security, data integrity, or performance.

3.3 OWNERSHIP AND RESERVATION OF RIGHTS
The license granted to you under this Agreement is limited and does not transfer to you any ownership rights or intellectual property interests in the GlucoSensor™ App or underlying medical technologies. Detailed information on ownership and intellectual property rights is addressed comprehensively in Article 7 of this Agreement. All rights not explicitly granted herein are expressly reserved by DiaX Medical and MicroTech Medical.

3.4 SOFTWARE UPDATES AND UPGRADES
DiaX Medical may periodically provide updates or upgrades to the GlucoSensor™ App (for example, to add new features, improve performance, fix bugs, or ensure regulatory compliance). Some updates may be required for the App to function safely and effectively. You agree to promptly download and install all provided updates. If you choose not to install an update, the App’s functionality, security, or compliance may be seriously diminished, and you assume all related risks. Your continued use of the App after installing an update constitutes acceptance of the changes introduced by that update. If you do not wish to accept a provided update, you must discontinue use of the App and uninstall it. If an update includes changes to the terms of this Agreement, you will be notified of those changes pursuant to Clause 1.6, and continued use of the App will constitute acceptance of the modified terms.

3.5 CONNECTIVITY AND DATA TRANSMISSION
The GlucoSensor™ App relies on stable Bluetooth connectivity and internet access between your mobile device and the CGM sensor. You acknowledge that connectivity disruptions may occasionally occur, resulting in delayed, incomplete, or interrupted glucose data.

You are responsible for ensuring your mobile device’s compatibility and adequate connectivity. DiaX Medical and MicroTech Medical disclaim liability for health-related decisions or outcomes based on delayed or incomplete glucose data resulting from connectivity issues.

Note: For complete details on limitations related to connectivity and device accuracy, see the full Legal Disclaimer for the App document incorporated by reference.

3.6 CUSTOMIZATION AND OVERRIDING OF CRITICAL ALERTS
The GlucoSensor™ App provides critical alerts designed to notify you promptly of urgent glucose trends or dangerous glucose levels. You have the option within the App to customize, silence, or override these alerts. However, altering or disabling these critical alerts carries substantial health and safety risks, including delayed or missed recognition of potentially life-threatening glucose events. You acknowledge and agree that customizing, disabling, or overriding critical alerts is solely at your own risk. DiaX Medical and MicroTech Medical explicitly disclaim any liability for harm, injury, or adverse health outcomes resulting from your customization or disabling of critical alerts.

ARTICLE 4: MEDICAL USE, DISCLAIMERS, AND RESPONSIBILITIES

4.1 INTENDED USE AND LIMITATIONS
The GlucoSensor™ CGM System (including the App) is intended solely as a supplementary tool for indicative glucose monitoring. It is not designed or approved to serve as the primary basis for diagnosing any condition, making critical treatment decisions, or managing acute glycaemic emergencies. Users must always verify any critical or unexpected glucose readings with traditional blood-glucose tests (fingerstick tests) before taking medical action. The App and CGM System are not a substitute for professional medical advice or judgment: you remain responsible for consulting a qualified healthcare provider about your diabetes management and health decisions. You must not rely on the App alone for important health decisions. DiaX Medical and MicroTech Medical expressly disclaim any liability for health outcomes resulting from a failure to seek appropriate medical advice or from relying solely on data provided by the App.

For full disclaimers and limitations, refer directly to the Legal Disclaimer for the App incorporated into this Agreement.

4.2 NOT FOR CRITICAL CARE OR EMERGENCY USE
As previously stated in the Medical Disclaimer (Summary) above, the App and CGM System are not for emergency or critical care use. Users must not depend solely on the App or CGM System for critical or emergency medical decisions. In the event of a suspected medical emergency (such as severe hypoglycaemia, severe hyperglycaemia, diabetic ketoacidosis, or loss of consciousness), Users must immediately seek professional medical assistance, use traditional glucose testing methods (fingerstick testing), or contact emergency medical services.

Alerts and Alarms Limitations:
Users must understand and acknowledge that alerts or alarms provided by the GlucoSensor™ App may occasionally fail or be missed due to factors such as device settings, connectivity disruptions, network delays, or user errors. You must never rely solely on App alarms or alerts to manage critical glucose levels or health situations. Always confirm glucose readings using traditional fingerstick tests and seek immediate medical help if symptoms are present or if you suspect an inaccurate reading or a missed alert.

DiaX Medical and MicroTech Medical explicitly disclaim any liability for adverse medical outcomes arising from reliance on the App or CGM System in critical or emergency situations.

4.3 DATA ACCURACY AND RELIABILITY
While MicroTech Medical ensures the CGM System meets EU medical device standards for accuracy, Users acknowledge that glucose readings provided by the App are indicative and may be influenced by various factors, including sensor placement, hydration levels, skin conditions, environmental conditions, and User handling. Due to inherent technological limitations, occasional inaccuracies or data gaps may occur.

DiaX Medical manages the data display and User interface aspects of the App, but the accuracy and reliability of glucose measurements remain the responsibility of MicroTech Medical, the system manufacturer. Users must regularly verify unexpected glucose readings through traditional blood glucose monitoring methods before making clinical decisions or treatment adjustments.

4.4 USER HEALTH RESPONSIBILITIES
Users must proactively consult their healthcare provider regarding medical questions, device use, glucose management strategies, or health-related decisions.

Users with Diabetes – Mandatory Medical Supervision:
If you have Type 1 diabetes or require intensive diabetes management (including insulin therapy), you must always consult and regularly engage with a qualified healthcare professional when using the GlucoSensor™ App and CGM System. The System is medically validated and CE-marked for adjunctive use in diabetes care, meaning it must supplement—not replace—professional medical guidance. Any adjustment to your treatment or medical decisions must be made only under the explicit direction and approval of your physician or healthcare provider.

Lifestyle and Wellness Users – Recommended Supervision:
For individuals using the CGM System solely for general wellness, weight management, or lifestyle purposes without diagnosed diabetes, regular medical supervision is not strictly required. However, you are still strongly encouraged to consult healthcare professionals if glucose readings indicate potential health concerns, significant lifestyle changes, or before initiating any significant dietary or exercise changes based on the App’s data.

4.5 RESPONSIBILITY FOR DEVICE AND DATA INTEGRITY
You are responsible for the proper maintenance and operation of your mobile device and the GlucoSensor™ CGM System. This includes keeping your device charged and secure, maintaining appropriate device settings/configurations, promptly installing all App software updates provided by DiaX Medical, and ensuring that the CGM sensor and transmitter are correctly used, calibrated (if applicable), replaced as recommended, and otherwise maintained in accordance with the manufacturer’s instructions. Failure to follow these guidelines or any provided maintenance schedule may result in inaccurate glucose data or diminished device performance. Neither DiaX Medical nor MicroTech Medical will be liable for any data inaccuracies, device failures, or health consequences arising from your negligence in device upkeep or from failing to adhere to the provided instructions. You assume full responsibility for any outcomes resulting from improper maintenance or use of the system. (Please refer to the Sensor Replacement Policy incorporated into this Agreement for detailed terms on sensor replacements and warranty coverage.)

4.6 SPECIFIC POPULATION LIMITATIONS
The GlucoSensor™ System has not been evaluated for all populations, including but not limited to individuals undergoing dialysis or those using implanted electronic medical devices (such as pacemakers). Use of the system by these or other medically vulnerable populations is explicitly not recommended unless specifically approved and monitored by a qualified healthcare professional. Users acknowledge this limitation and assume full responsibility if choosing to use the system without professional oversight.

The GlucoSensor™ CGM System has not been specifically validated for use during pregnancy. Pregnant Users should rely on traditional blood glucose testing methods and consult a qualified healthcare professional before and during the use of this System. DiaX Medical and MicroTech Medical explicitly disclaim liability for any outcomes resulting from use of the System during pregnancy without medical oversight.

4.7 USER ACKNOWLEDGMENT OF RISKS
By using the GlucoSensor™ CGM System and App, you acknowledge and accept the inherent risks associated with using digital medical monitoring technologies, including but not limited to:

Potential inaccuracies in glucose measurement under certain conditions.
Occasional connectivity disruptions causing delayed or incomplete data transmission.
Risks related to User error in placing, calibrating, or maintaining CGM sensors and devices.

You agree to regularly consult your healthcare provider to assess the appropriateness of continuing to use the CGM System for your individual health management needs.

4.8 REGULATORY COMPLIANCE
The GlucoSensor™ CGM System is a CE-marked medical device currently compliant with the Medical Device Directive 93/42/EEC (MDD) and in transition towards full compliance with the Medical Device Regulation (MDR) 2017/745 by December 31, 2027. DiaX Medical and MicroTech Medical will ensure continued regulatory compliance throughout this transition.

Use of the CGM System in jurisdictions outside its regulatory approval scope is at your own risk, and DiaX Medical disclaims any liability arising from such unauthorized use.

ARTICLE 5: REPORTING TO REGULATORY AUTHORITIES

5.1 USER REPORTING RIGHTS
Detailed roles and responsibilities of DiaX Medical, MicroTech Medical, and the Authorized Representative are provided in the Definitions section of this Agreement.

Nothing in this Agreement restricts or prevents Users from directly reporting device-related safety, performance, or compliance concerns to their local EU medical regulatory authorities as permitted or required under applicable EU laws and regulations. Users are encouraged to report any serious incidents or concerns related to device safety and performance promptly. For guidance on reporting, Users may contact DiaX Medical directly, who will facilitate appropriate communication with MicroTech Medical and the Authorized Representative (Lotus NL B.V.), or users may contact their national regulatory authority directly.

ARTICLE 6: PRIVACY AND DATA PROTECTION

6.1 COLLECTION AND USE OF PERSONAL DATA
DiaX Medical collects, processes, and stores personal data (such as your name, contact information, and device details) and health-related data (such as glucose readings and other relevant medical information) through your use of the GlucoSensor™ App and CGM System. The detailed purposes, methods, and legal basis for processing your data are comprehensively described in the DiaX Medical Privacy Policy, which is incorporated into this Agreement by reference.

By downloading, installing, or activating the App, you will be prompted to explicitly consent to DiaX Medical collecting, processing, storing, and using your personal and health-related data as detailed in this Agreement and the Privacy Policy. Explicit consent will be requested through a clear consent screen in the App. If you do not explicitly consent, you must not use the App. Your explicit consent is required under GDPR due to the sensitive nature of health-related data processed by the App.

6.2 DATA SECURITY AND SAFEGUARDS
DiaX Medical employs robust technical and organizational measures designed to protect your personal and health data from unauthorized access, alteration, disclosure, or destruction. Such security measures include data encryption, secure servers, restricted data access, regular security assessments, and compliance audits.

However, due to the inherent risks of data transmission over the internet and electronic storage systems, DiaX Medical cannot guarantee absolute security of your data. You acknowledge and accept that transmission and storage of data involve inherent security risks. DiaX Medical continually evaluates and updates security protocols to minimize these risks.

6.3 THIRD-PARTY SERVICE PROVIDERS
To facilitate the functionalities of the App and CGM System, DiaX Medical engages trusted third-party service providers, including cloud hosting providers, IT security services, customer support platforms, and payment processors. These third parties may have limited access to your personal data strictly for performing designated tasks on behalf of DiaX Medical.

All third-party providers are contractually bound by strict confidentiality obligations and are required to adhere to applicable EU data protection laws, including the GDPR. DiaX Medical does not sell or commercially exploit your personal or health data to third parties for unrelated purposes.

DATA SHARING WITH MICROTECH MEDICAL
DiaX Medical may share certain anonymized or de-identified system performance data with MicroTech Medical to facilitate improvements, technical maintenance, accuracy verification, and compliance obligations. Such data transfers are conducted strictly in compliance with GDPR requirements and safeguards, ensuring the protection of User privacy as described in the Privacy Policy.

6.4 USER RIGHTS UNDER GDPR
Under GDPR, you have specific rights concerning your personal and health data, including the rights to access, rectify, erase, restrict processing, request data portability, and object to processing under certain conditions. You may also withdraw your consent for data processing at any time. Exercising these rights may limit or affect your ability to use the App or its functionalities.

To exercise any of your GDPR-related rights or to inquire about data handling practices, you may contact DiaX Medical directly via the contact information provided in Article 16 of this Agreement and in the Privacy Policy.

6.5 DATA BREACH NOTIFICATION
In the unlikely event of a data breach impacting your personal data’s confidentiality, integrity, or availability, DiaX Medical will promptly notify affected Users and the appropriate EU supervisory authorities as mandated by GDPR. Notification will occur without undue delay, typically within 72 hours of identifying the breach, unless it is unlikely to result in risks to individuals’ rights and freedoms.

6.6 INTERNATIONAL DATA TRANSFERS
Personal and health-related data collected by the App may occasionally be transferred to and processed in countries outside the European Economic Area (EEA), primarily when utilizing cloud-based services or infrastructure. DiaX Medical ensures that appropriate safeguards are implemented, including the use of standard contractual clauses approved by the European Commission, binding corporate rules, or certifications demonstrating compliance with EU-equivalent data protection standards.

By using the App, you consent to these transfers under the conditions outlined in the Privacy Policy. DiaX Medical is committed to ensuring the protection of your data regardless of transfer locations.

ARTICLE 7: INTELLECTUAL PROPERTY RIGHTS

7.1 OWNERSHIP OF INTELLECTUAL PROPERTY
The GlucoSensor™ App—including visual design, user interfaces, graphics, logos, trademarks, software code developed by DiaX Medical (excluding medical algorithms, the medical Software Development Kit (SDK), and underlying CGM technology)—and all related documentation constitute intellectual property exclusively owned by or licensed to DiaX Medical.
The underlying medical algorithms, glucose measurement technologies, the medical SDK, sensor technologies, transmitter hardware, and other core medical device functionalities integrated within the App remain exclusively owned by MicroTech Medical (Hangzhou) Co., Ltd. This Agreement does not transfer to you any ownership rights or intellectual property interests; all such rights remain strictly with DiaX Medical, MicroTech Medical, or their respective licensors.

7.2 USER-GENERATED CONTENT
If you submit, upload, or otherwise provide content through the GlucoSensor™ App—including feedback, suggestions, reviews, comments, or similar communications—you grant DiaX Medical a perpetual, irrevocable, royalty-free, transferable, worldwide license to use, modify, reproduce, adapt, distribute, publish, translate, create derivative works from, publicly perform, and display such user-generated content in connection with DiaX Medical’s operations, products, marketing, and promotional activities.
You warrant that you own or have secured all necessary rights to provide this content and that its use by DiaX Medical will not infringe third-party intellectual property rights, privacy rights, or other legal rights.

7.3 THIRD-PARTY CONTENT AND LINKS
The GlucoSensor™ App may include third-party content or links to third-party websites or services that DiaX Medical does not control. DiaX Medical explicitly disclaims responsibility or liability for the accuracy, reliability, security, or practices of these third-party websites or services. The presence of such third-party content or links does not imply endorsement or recommendation by DiaX Medical. Any use of or interaction with third-party content or services is solely at your risk and subject to the third party’s own terms and conditions.

7.4 THIRD-PARTY SOFTWARE AND OPEN-SOURCE COMPONENTS
The App may incorporate embedded third-party software components, including open-source libraries or frameworks governed by their respective license agreements. Your use of these embedded components is strictly subject to their applicable licenses. In the event of any conflict between these licenses and this Agreement, the third-party licenses will prevail regarding the respective components. You may request details on specific third-party software and related license terms by contacting DiaX Medical as specified in Article 16.

7.5 INFRINGEMENT NOTIFICATION
If you believe any content accessible through the GlucoSensor™ App infringes your intellectual property rights, notify DiaX Medical promptly, in writing, at the contact details provided in Article 16. Your notice must include a specific identification of the infringing material, a detailed description of your intellectual property rights, your contact information, and a formal statement affirming your good-faith belief that use of the material is unauthorized. DiaX Medical will promptly respond and take appropriate remedial action in accordance with applicable intellectual property laws.

ARTICLE 8: WARRANTIES, DISCLAIMERS, AND LIABILITY LIMITATIONS

8.1 GENERAL WARRANTY DISCLAIMER
The GlucoSensor™ App is provided strictly on an “as is” and “as available” basis. To the fullest extent permitted by applicable law, DiaX Medical explicitly disclaims all warranties and conditions—whether express, implied, statutory, or otherwise—including but not limited to implied warranties of merchantability, fitness for a particular purpose, reliability, accuracy, availability, security, and non-infringement. DiaX Medical provides no warranty that the App will operate uninterrupted or error-free or that all defects or issues will be corrected promptly or completely.

8.2 MEDICAL WARRANTY DISCLAIMER
The GlucoSensor™ App and related CGM System functionalities are intended solely for indicative glucose monitoring to support lifestyle, wellness, and diabetes management purposes. They are not medical diagnostic tools and are neither intended nor approved for standalone medical decision-making or clinical diagnosis purposes. You must always confirm glucose readings from the App using a traditional fingerstick blood glucose test before making medical decisions or adjustments to treatment.

DiaX Medical explicitly disclaims any and all liability for adverse medical outcomes arising from reliance solely on indicative glucose data without additional verification using traditional methods and without consultation with qualified healthcare professionals. For full medical warnings and limitations, refer directly to the separate Legal Disclaimer for the App, accessible within the App by navigating to Settings > About & Legal > Disclaimer, and also available on the GlucoSensor.com website.

8.3 LIABILITY LIMITATION FOR MEDICAL DATA ACCURACY
DiaX Medical exclusively manages the visual display and user interface aspects of glucose data in the App. MicroTech Medical, as the manufacturer, retains exclusive responsibility for the accuracy, reliability, medical validity, and clinical performance of the underlying glucose measurement data, medical Software Development Kit (SDK), algorithms, and all related medical functionalities. Users acknowledge and accept inherent limitations of continuous glucose monitoring (CGM) technologies, including potential inaccuracies or interruptions caused by physiological factors, environmental conditions, sensor placement, or user handling. DiaX Medical and MicroTech Medical explicitly disclaim liability for medical decisions or adverse health outcomes arising from CGM data unless confirmed by traditional glucose testing methods and proper medical supervision.

8.4 LIMITATION OF LIABILITY
To the maximum extent permitted by applicable law, neither DiaX Medical nor MicroTech Medical—nor any of their directors, officers, employees, affiliates, licensors, or service providers—shall be liable for any indirect, incidental, special, consequential, exemplary, or punitive damages or any loss of profits, revenue, data, or business opportunities arising from or related to your use or inability to use the GlucoSensor™ App or the CGM System, regardless of the form of action (contract, tort, negligence, strict liability, or otherwise), even if DiaX Medical or MicroTech Medical has been advised of the possibility of such damages.
The total aggregate liability of DiaX Medical arising under or in connection with this Agreement or your use of the App is strictly limited to the greater of:
(a) the total amount paid by you (if any) for using the App within the six (6) months preceding the claim; or
(b) €50.00 (fifty euros).
This liability limitation shall apply even if the above remedy fails its essential purpose, provided such limitation is permitted under applicable law.

Exception:
Nothing in this Agreement excludes or limits DiaX Medical’s or MicroTech Medical’s liability for death, personal injury, fraud, gross negligence, or wilful misconduct, nor any other liability that cannot be excluded or limited under applicable EU law, including mandatory obligations arising from the EU Product Liability Directive (Directive 85/374/EEC).

8.5 DISCLAIMER FOR DATA LOSS
DiaX Medical expressly disclaims liability for any loss, corruption, or unauthorized disclosure of your data—including personal, health-related, and usage data—that may result from technical failures, software errors, cyberattacks, security breaches, or circumstances beyond DiaX Medical’s reasonable control. You bear sole responsibility for regularly backing up and securely maintaining your data.

8.6 FORCE MAJEURE
DiaX Medical shall not be liable or responsible for any failure or delay in the performance of its obligations under this Agreement caused by events beyond its reasonable control (“Force Majeure”), including but not limited to natural disasters, pandemics, acts of war, terrorism, government restrictions, power failures, cyberattacks, network disruptions, labor strikes, or similar uncontrollable circumstances. DiaX Medical will make reasonable efforts to resume services promptly once such Force Majeure events cease but disclaims any liability for interruptions, delays, or reduced availability of the App or related services caused by these events.

8.7 APPLICABILITY OF LIABILITY LIMITATIONS
Certain jurisdictions may prohibit or restrict the exclusion or limitation of liability for incidental, consequential, or other damages as described above. In such jurisdictions, the limitations or exclusions provided in this Article shall apply only to the fullest extent permitted by applicable local law. Should any provision in this Article be found unenforceable or limited by applicable law, such provision shall be enforced to the maximum permissible extent, and the remaining provisions shall remain in full force and effect.

8.8 THIRD-PARTY BENEFICIARIES
MicroTech Medical and Lotus NL B.V. are explicitly recognized as third-party beneficiaries to the disclaimers and liability limitations in this Article 8 and may enforce these terms directly against Users.

ARTICLE 9: INDEMNIFICATION

9.1 USER INDEMNIFICATION OBLIGATIONS
You agree to indemnify, defend, and hold harmless DiaX Medical B.V., MicroTech Medical (Hangzhou) Co., Ltd., and their respective affiliates, subsidiaries, licensors, service providers, and each of their directors, officers, employees, representatives, agents, successors, and assigns (collectively, the “Indemnified Parties”) from and against any and all claims, demands, liabilities, losses, damages, judgments, awards, costs, fees (including reasonable attorneys’ fees and court costs), or expenses resulting from or arising out of:

your breach or violation of this Agreement or any incorporated document (including the Privacy Policy or Legal Disclaimer for the App);
your misuse, unauthorized use, negligent use, or improper handling of the GlucoSensor™ App, CGM System, or any related products, software, or services;
your infringement or alleged infringement of intellectual property rights, privacy rights, data protection laws, or any other third-party rights related to your use of the App or associated services;
your violation of applicable local, national, or EU laws, regulations, or standards, including but not limited to medical device regulations, data protection (GDPR) obligations, or consumer protection laws;
your submission, transmission, or uploading of incorrect, incomplete, misleading, unlawful, harmful, or otherwise inappropriate data or user-generated content via the App or through any associated DiaX Medical services;
medical decisions, actions, or outcomes arising from your sole reliance upon indicative glucose data provided by the App without appropriate verification through traditional fingerstick blood glucose tests and without professional medical consultation.

9.2 INDEMNIFICATION PROCEDURE
Upon becoming aware of any claim or proceeding potentially subject to indemnification under this Agreement, DiaX Medical will promptly provide you with written notice detailing the claim, demand, or legal proceeding. DiaX Medical agrees to reasonably cooperate with you, at your sole expense, in the defense or settlement of such claim or proceeding. DiaX Medical reserves the right, at your expense, to assume sole and exclusive defense and control over any matter subject to indemnification. In such circumstances, you agree to cooperate fully in DiaX Medical’s defense efforts.
You shall not settle, compromise, or resolve any indemnifiable claim or proceeding without the prior written consent of DiaX Medical if the settlement or resolution imposes any obligation, liability, or restriction on DiaX Medical, MicroTech Medical, or any other Indemnified Party, or otherwise adversely affects their rights, interests, or reputations.

ARTICLE 10: TERMINATION

10.1 TERMINATION BY DIAX MEDICAL
DiaX Medical reserves the right, at its sole discretion, to immediately terminate or suspend your license to use and access the GlucoSensor™ App and any related services without prior notice or liability to you if:

you breach any term or provision of this Agreement or any incorporated document, including but not limited to the Privacy Policy and Legal Disclaimer for the App;
your use of the App or the CGM System poses or may pose a security, regulatory, or safety risk to DiaX Medical, MicroTech Medical, or other users;
you engage in unauthorized, unlawful, or fraudulent activities involving the App or the CGM System, or otherwise violate applicable laws, regulations, or guidelines;
your actions or omissions harm, threaten to harm, or compromise the safety, reliability, security, integrity, or reputation of the GlucoSensor™ App, CGM System, DiaX Medical, MicroTech Medical, or associated services;
termination or suspension is mandated by regulatory, legal, or safety obligations imposed upon DiaX Medical.

DiaX Medical reserves the right to entirely discontinue or restrict the availability of the App or any associated services at any time for regulatory, safety-related, operational, legal, or business reasons, without liability to you or any other third party. Upon termination or suspension, you must immediately cease all use of the App, uninstall it from all your devices, and delete or destroy any related software, documentation, or data in your possession.

All provisions of this Agreement which, by their nature, should reasonably survive termination—including intellectual property ownership, disclaimers of warranties, liability limitations, indemnification obligations, data protection obligations, and dispute resolution clauses—shall remain in full force and effect following termination or expiration of this Agreement.

10.2 TERMINATION BY USER
You may terminate this Agreement at any time by uninstalling the GlucoSensor™ App from your device(s) and discontinuing all further use of the App and associated services. Termination by you does not entitle you to a refund or compensation for any previously paid fees, services, or products unless explicitly stated in a separate applicable policy (e.g., the Returns and Refund Policy).

10.3 CONSEQUENCES OF TERMINATION
Upon termination of this Agreement, for any reason:

All licenses, rights, and permissions granted to you under this Agreement immediately cease.
You must immediately discontinue all use of the GlucoSensor™ App and uninstall it from all your devices.
DiaX Medical reserves the right, without further notice, to deactivate or delete your user account, including all associated personal and health data, subject to the data retention and deletion provisions specified in the Privacy Policy.
Any provision of this Agreement that by its nature should survive termination shall continue in full force and effect after termination, including but not limited to provisions regarding intellectual property rights, data privacy, medical disclaimers, limitations of liability, indemnification, and dispute resolution.

Termination shall not affect any rights or obligations that accrued prior to the effective date of termination.

ARTICLE 11: SEVERABILITY
If any provision of this Agreement is held by a court or competent arbitration tribunal to be invalid, illegal, or unenforceable, that provision shall be limited or eliminated to the minimum extent necessary so that this Agreement shall otherwise remain fully enforceable and in effect. In such case, the parties agree to replace the invalid or unenforceable provision with a valid, enforceable provision that most closely achieves the original intent and economic effect of the replaced provision, preserving the spirit and commercial purpose of this Agreement to the maximum extent possible.

The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provisions, which shall remain binding and enforceable.

ARTICLE 12: WAIVER AND ASSIGNMENT

12.1 WAIVER
No waiver by DiaX Medical of any term, condition, or provision of this Agreement shall be considered a continuing waiver or a waiver of any subsequent breach of the same or any other term. Any failure or delay by DiaX Medical to enforce or exercise any right, power, or remedy under this Agreement shall not constitute a waiver of that right or any other right. Any single or partial exercise of any right or remedy does not preclude the further exercise of that right or the exercise of any other rights or remedies under this Agreement.
To be legally valid, any waiver by DiaX Medical must be explicit, in writing, and signed by an authorized representative of DiaX Medical.

12.2 ASSIGNMENT
You may not assign, transfer, delegate, or subcontract any of your rights or obligations under this Agreement to any third party without the prior express written consent of DiaX Medical. Any attempted assignment, delegation, transfer, or subcontracting without such consent shall be null, void, and shall constitute a material breach of this Agreement.
DiaX Medical reserves the unrestricted right, at its sole discretion and without your consent, to freely assign, transfer, delegate, or subcontract any or all of its rights or obligations under this Agreement to any affiliate, successor entity, acquirer, or third party in connection with a merger, acquisition, sale of assets, restructuring, or similar corporate transaction.
This Agreement shall be binding upon and shall inure to the benefit of DiaX Medical, its successors, permitted assigns, and you.

12.3 THIRD-PARTY BENEFICIARY RIGHTS
MicroTech Medical and Lotus NL B.V. are expressly recognized third-party beneficiaries of specific provisions in this Agreement related to liability limitations, warranty disclaimers, indemnification, and dispute resolution (particularly as stated in Articles 8, 9, and 13). Third-party beneficiary rights are further detailed explicitly in Article 8.

ARTICLE 13: GOVERNING LAW AND DISPUTE RESOLUTION

13.1 DISPUTE RESOLUTION PROCEDURE

Disputes shall be resolved through the following sequence of procedures unless otherwise provided by mandatory consumer laws.

Informal Negotiation:
In the event of any dispute, claim, or controversy arising from or related to this Agreement, you agree first to attempt informal resolution by contacting DiaX Medical in writing, using the contact information provided in Article 16 (“Contact Information”). DiaX Medical will respond within thirty (30) days and negotiate in good faith to attempt to resolve the dispute amicably.

Disputes Involving Medical Device Performance or Regulatory Compliance:
If your dispute specifically concerns medical accuracy, performance, safety, or regulatory compliance of the GlucoSensor™ CGM System, you should first notify DiaX Medical. DiaX Medical will coordinate with the legal manufacturer (MicroTech Medical) and its Authorized Representative (Lotus NL B.V.) as required by applicable EU medical device regulations (MDD/MDR) to appropriately address your concerns.
Nothing in this clause limits your statutory right to directly report device-related safety or performance concerns to relevant EU regulatory authorities as permitted by applicable EU law.

Binding Arbitration:
If the dispute is not resolved through informal negotiation within sixty (60) days from the initial notice, the dispute shall be finally and exclusively settled by binding arbitration in accordance with the Arbitration Rules of the International Chamber of Commerce (ICC). Arbitration will be conducted by a single arbitrator, in English, and held in Amsterdam, Netherlands. The arbitration award shall be final, binding, and enforceable in any competent court.

EU Consumer Rights and Exceptions:
This arbitration clause does not limit or exclude statutory rights under applicable EU or national consumer protection laws. As an EU-based consumer, you retain the right to bring claims related to consumer rights before the competent courts in your country of residence, irrespective of the arbitration provision outlined above.

13.2 WAIVER OF CLASS ACTION AND JURY TRIAL
You explicitly agree to resolve all disputes individually and waive any right to participate in or initiate class actions, collective actions, representative actions, or any form of consolidated proceedings against DiaX Medical or MicroTech Medical (Hangzhou) Co., Ltd. arising from your use of the App or related to this Agreement. You also expressly waive your right to a jury trial for any dispute, controversy, or claim arising from or related to this Agreement.

13.3 EXCEPTIONS TO ARBITRATION REQUIREMENT
Notwithstanding the arbitration requirement described above, DiaX Medical retains the right to seek injunctive relief or other equitable remedies from any competent court to prevent or address irreparable harm or immediate threats arising from violations or breaches of intellectual property rights, confidentiality obligations, or data security requirements pending the resolution of arbitration proceedings.

13.4 OPT-OUT OF ARBITRATION PROVISION
You may opt out of the binding arbitration provision by providing explicit written notice to DiaX Medical of your intent to opt-out within thirty (30) days following your initial acceptance of this Agreement or the first installation of the App, whichever occurs first. Your opt-out notice must clearly indicate your intent to opt out of arbitration and must be sent using the contact information provided in Article 16.
If you validly opt out of arbitration, any disputes arising from or related to this Agreement shall be exclusively submitted to the competent courts located in Amsterdam, Netherlands, unless mandatory consumer protection laws applicable to your jurisdiction require otherwise.

13.5 CONSUMER PROTECTION AND CROSS-BORDER DISPUTES
Nothing in this Agreement limits or deprives EU consumers of mandatory protections or rights under applicable consumer laws. If you reside within the European Union, you retain the right to bring proceedings relating to consumer disputes in the competent courts of your country of residence or in Amsterdam, Netherlands, in accordance with EU consumer protection regulations. For EU-based consumers, arbitration remains optional, and you explicitly retain your statutory right to resolve disputes through your local jurisdiction’s competent courts.

ARTICLE 14: ENTIRE AGREEMENT
This Agreement, together with all documents expressly incorporated herein by reference (including but not limited to the Privacy Policy, the Legal Disclaimer for the Website, the Legal Disclaimer for the App, the Website EULA, General Delivery Terms, Returns and Refund Policy, and Sensor Replacement Policy), constitutes the entire and exclusive understanding between you and DiaX Medical regarding your use of the GlucoSensor™ App and supersedes any and all prior or contemporaneous agreements, communications, and understandings, whether written or oral, concerning the subject matter of this Agreement.

In the event of any conflict or inconsistency between the terms of this Agreement and any incorporated documents, the specific terms relevant to the issue in question will prevail (e.g., Privacy Policy for data protection matters, Legal Disclaimer for medical limitations, etc.).

No terms, representations, warranties, or conditions not explicitly stated or incorporated herein shall be binding on either party. You acknowledge that, by accepting this Agreement, you have not relied upon any representation, statement, or promise not explicitly set forth herein.

ARTICLE 15: LANGUAGE DISCLAIMER
This Agreement may be made available to Users in multiple languages for convenience. In the event of any inconsistency, discrepancy, or conflict in interpretation between the English version of this Agreement and any translated version, the English language version shall prevail and be considered the legally binding and authoritative version. DiaX Medical assumes no liability for misunderstandings or disputes arising from translation inaccuracies. For clarification or legal certainty, always consult the English version or contact DiaX Medical directly.

ARTICLE 16: CONTACT INFORMATION
If you have any questions, concerns, or requests regarding this Agreement, the App, or associated services, please contact us at:

DiaX Medical B.V.
Vincent van Goghweg 5
1861 CD Bergen, Netherlands
Email: info@diaxmedical.com

Please note that this address is intended solely for correspondence purposes. It is not accessible for visits or in-person inquiries.

V140425